SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-16-006700
Filing Date
2016-03-25
Accepted
2016-03-25 15:57:20
Documents
51
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT sbfm_10k.htm 10-K 930072
2 CERTIFICATION sbfm_ex311.htm EX-31 14140
3 CERTIFICATION sbfm_ex312.htm EX-31 14219
4 CERTIFICATION sbfm_ex32.htm EX-32 6511
5 img001.jpg GRAPHIC 35883
6 img002.jpg GRAPHIC 35053
7 img003.jpg GRAPHIC 20907
  Complete submission text file 0001354488-16-006700.txt   3220000

Data Files

Seq Description Document Type Size
8 sbfm-20151231.xml EX-101.INS 555357
9 sbfm-20151231.xsd EX-101.SCH 29910
10 sbfm-20151231_cal.xml EX-101.CAL 37751
11 sbfm-20151231_def.xml EX-101.DEF 43772
12 sbfm-20151231_lab.xml EX-101.LAB 179968
13 sbfm-20151231_pre.xml EX-101.PRE 136228
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52898 | Film No.: 161529776
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services